Herceptin (R) - from laboratory to cure in breast cancer?

被引：0
|
作者：
Cameron, D. [1 ,2 ]
机构：
[1] Western Gen Hosp, Edinburgh, Midlothian, Scotland
[2] Univ Edinburgh, Edinburgh, Midlothian, Scotland
来源：
JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH | 2007年 / 37卷 / 02期
关键词：
Breast cancer; HER2; Herceptin (R); trastuzumab;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
There has been considerable publicity surrounding the potential benefits of herceptin in treating early breast cancer and whether or not its benefits outweigh the costs of treatment. In this article, requested by visitors to the www.behindthemedicalheadlines.com site, Dr David Cameron provides an overview of the development of herceptin, its use in treatment and its safety profile.
引用
收藏
页码：112 / 116
页数：5
相关论文
共 50 条
  • [41] Herceptin monotherapy in HER2(+)-recurrent breast cancer
    Eidtmann, H
    [J]. ONKOLOGIE, 2002, 25 : 14 - 15
  • [42] Retrospective analysis of the safety of Herceptin® immunotherapy in metastatic breast cancer
    Cook-Bruns, N
    [J]. ONCOLOGY, 2001, 61 : 58 - 66
  • [43] Overview of treatment results with trastuzumab (Herceptin) in metastatic breast cancer
    Hortobagyi, GN
    [J]. SEMINARS IN ONCOLOGY, 2001, 28 (06) : 43 - 47
  • [44] Her2-positive breast cancer: Herceptin and beyond
    Dean-Colomb, Windy
    Esteva, Francisco J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2008, 44 (18) : 2806 - 2812
  • [45] Herceptin as a single agent in the treatment of patients with metastatic breast cancer
    Zhang, Mingliang
    Guo, Wei
    Qian, Jun
    Wang, Benzhong
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (05) : C125 - C127
  • [46] Trastuzumab (herceptin) and HER2-positive breast cancer
    Murray, S
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 174 (01) : 36 - 37
  • [47] Herceptin raises its sights beyond advanced breast cancer
    Mukai, K
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1998, 28 (08) : 525 - 525
  • [48] Ultrasound-triggered herceptin liposomes for breast cancer therapy
    Amal Elamir
    Saniha Ajith
    Nour Al Sawaftah
    Waad Abuwatfa
    Debasmita Mukhopadhyay
    Vinod Paul
    Mohammad H. Al-Sayah
    Nahid Awad
    Ghaleb A. Husseini
    [J]. Scientific Reports, 11
  • [49] Efficacy and safety of Herceptin® in women with metastatic breast cancer:: results from pivotal clinical studies
    Smith, IE
    [J]. ANTI-CANCER DRUGS, 2001, 12 : S3 - S10
  • [50] Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer
    Tanner, M
    Kapanen, AI
    Junttila, T
    Raheem, O
    Grenman, S
    Elo, J
    Elenius, K
    Isola, J
    [J]. MOLECULAR CANCER THERAPEUTICS, 2004, 3 (12) : 1585 - 1592
12345